{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T12:05:18Z","timestamp":1744545918873},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jbspin.2013.11.003","type":"journal-article","created":{"date-parts":[[2013,12,8]],"date-time":"2013-12-08T02:45:48Z","timestamp":1386470748000},"page":"274-275","source":"Crossref","is-referenced-by-count":4,"title":["Rosacea associated with etanercept"],"prefix":"10.1016","volume":"81","author":[{"given":"Ayten","family":"Yazici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysun Sikar","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Cefle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Bayramgurler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kursat Demir","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2013.11.003_bib0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/00002018-200629080-00004","article-title":"Safety of etanercept in psoriasis: a critical review","volume":"29","author":"Sanchez Carazo","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.jbspin.2013.11.003_bib0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-\u03b1-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2013.11.003_bib0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2008.10.060","article-title":"Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review","volume":"61","author":"Moustou","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2013.11.003_bib0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/gut.2008.163683","article-title":"Dermatological complications and safety of anti-TNF treatments","volume":"58","author":"Kerbleski","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2013.11.003_bib0025","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00105-008-1533-z","article-title":"A case of granulomatous rosacea coinciding with the use of etanercept: no relaps with infliximab","volume":"59","author":"Winter","year":"2008","journal-title":"Hautarzt"},{"key":"10.1016\/j.jbspin.2013.11.003_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2340\/00015555-0681","article-title":"Severe rosacea in a patient on infliximab for ulcerative colitis: pathophysiological considerations","volume":"89","author":"Kosmidou","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jbspin.2013.11.003_bib0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1468-3083.2001.00308.x","article-title":"Rosacea fulminans triggered by high-dose vitamins B6 and B12","volume":"15","author":"Jansen","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jbspin.2013.11.003_bib0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea: I.\u00a0Etiology, pathogenesis, and subtype classification","volume":"51","author":"Crowford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2013.11.003_bib0045","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increase serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X13002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X13002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T09:27:20Z","timestamp":1538990840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X13002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1297319X13002558"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2013.11.003","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}